By Mecwins
In this context, focusing on fluid biomarkers, the AVAC technology developed by Mecwins provides high robustness and greater sensitivity in measuring the analytes of interest. This advancement could lead to more accurate results, allowing for a clearer definition and study of AD and its progression.
